医学部

岡地 祥太郎

shotaro okachi

基本情報

所属
藤田医科大学 医学部 呼吸器内科学 講師

J-GLOBAL ID
202301017361544135
researchmap会員ID
R000052757

研究キーワード

 2

学歴

 1

論文

 24
  • Shotaro Okachi, Maki Sugimoto, Takuma Ina, Tomoya Horiguchi, Yasuhiro Goto, Naozumi Hashimoto, Michitaka Fujiwara, Kazuyoshi Imaizumi
    Annals of the American Thoracic Society 22(4) 609-611 2025年4月  
  • Kumiko Yamatsuta, Shotaro Okachi, Shin Hasegawa, Maki Ota, Hisashi Kako, Takuma Ina, Tomoya Horiguchi, Yuko Oya, Yasuhiro Goto, Naozumi Hashimoto, Kazuyoshi Imaizumi
    BMC pulmonary medicine 24(1) 632-632 2024年12月26日  
    BACKGROUND: The increasing prevalence of lung cancer in the elderly population necessitates a closer evaluation of diagnostic and therapeutic approaches. This study aimed to compare the safety and diagnostic efficacy of transbronchial lung cryobiopsy (TBLC) between patients ≥ 80 years and younger patients. METHODS: A retrospective review was conducted of 96 patients diagnosed with peripheral lung cancer who underwent TBLC between April 2021 and October 2023. The patients were categorized into two groups: the elderly group (age ≥ 80 years, n = 20) and younger group (age < 80 years; n = 76). Data regarding the biopsy yield, complications, and feasibility of molecular analyses were collected and analyzed. RESULTS: The diagnostic yield of TBLC was comparable between the elderly and younger groups (95% vs. 89.5%, p = 0.679). Biomarker testing, including programmed death-ligand 1 expression and genetic mutations, were feasible in all cases diagnosed with cancer using TBLC samples. No significant differences were observed in major complications such as pneumothorax or bleeding. CONCLUSIONS: TBLC was found to be a safe and effective diagnostic tool for peripheral lung cancer in elderly patients and provided adequate samples for molecular testing. Since the complication rates did not significantly differ between the two age groups, age alone should not be considered a contraindication for the procedure.
  • Takayasu Ito, Kazuki Nishida, Shingo Iwano, Shotaro Okachi, Shota Nakamura, Masahiro Morise, Chen Yoshikawa Fengshi Toyofumi, Makoto Ishii
    Journal of Bronchology and Interventional Pulmonology 31(4) 2024年9月13日  
  • Shoji Okado, Shota Nakamura, Keiyu Sato, Harushi Ueno, Takayasu Ito, Kazuhide Sato, Shotaro Okachi, Yohei Uehara, Misa Matsumoto, Natsumi Shimazaki, Katsuya Miyagawa, Toyofumi Fengshi Chen-Yoshikawa
    Respiration; international review of thoracic diseases 1-7 2024年7月30日  
    INTRODUCTION: A minimally invasive alternative to surgery for treating pneumothorax has been developed, aiming to reduce risks while maintaining efficacy. This study conducted basic experiments using ex vivo and in vivo pig lung employing a super-thin catheter for treatment. This new device injects fibrin glue directly into the responsible lesion to close the air leak, which has two features: thin design and double-lumen. METHODS: The experimental setup involved utilizing trachea and both lung specimens from pigs under positive pressure ventilation. To simulate pneumothorax, artificial fistulas were created on the lung surfaces. The super-thin catheter, guided through a bronchoscope near the fistula, was used to embolize the peripheral bronchus by injecting a fibrin preparation. Then, an air leak test was conducted afterward to assess the efficacy of the treatment. Additionally, a similar pneumothorax model was induced in alive pig under general anesthesia to evaluate its curability. RESULTS: In the extracted pig lungs, embolization was performed in 21 cases, resulting in the cessation of air leaks in 19 cases, corresponding to a 90.5% cure rate. Notably, no major adverse events occurred with the treatment devices. Similarly, in living pigs, pneumothorax was successfully treated, with no recurrence observed up to the seventh postoperative day. CONCLUSION: The novel treatment device utilizing a super-thin catheter offers a minimally invasive and highly curative option for pneumothorax. These promising results suggest the potential for further development and human clinical trials, which could revolutionize the treatment of pneumothorax, reducing risks and improving outcomes.
  • Shotaro Okachi, Toshinori Matsui, Manami Sakurai, Takayasu Ito, Masahiro Morise, Kazuyoshi Imaizumi, Makoto Ishii, Michitaka Fujiwara
    Journal of ultrasonography 24(96) 20240012-20240012 2024年2月  
    AIM: This study aimed to examine the feasibility and potential benefits of an optical see-through head-mounted display (OST-HMD) during real-time ultrasound-guided thoracentesis simulations. MATERIAL AND METHODS: Six physicians performed a thoracentesis simulation using an OST-HMD and a wireless image transmission system. The time required, puncture needle visibility, pleural fluid collection success rate, and head movement during the procedure using a smart glass equipped with an inertial measurement unit were all recorded and compared with and without the HMD. RESULTS: Study participants successfully extracted effusions in all procedures. The use of OST-HMD did not significantly affect the time of the procedure, but notably decreased the horizontal and vertical head movements during the procedure. CONCLUSIONS: The study demonstrated the feasibility of using an OST-HMD in a simulated real-time ultrasound-guided thoracentesis procedure and showed the potential of HMD in thoracentesis to improve ergonomics and accuracy. Further research is necessary to confirm these findings.

MISC

 2

共同研究・競争的資金等の研究課題

 4

産業財産権

 2